Clinical Trial Update: The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma

View source ↗

Summary

Clinical trial update investigating CD24 expression as a potential 'do-not-eat-me' signal in cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Cholangiocarcinoma | Status: ACTIVE_NOT_RECRUITING